NCT02385318View on ClinicalTrials.gov

To Compare Safety and Efficacy of Perrigo's Drug Product Compared to an FDA Approved Drug Product in the Treatment of Actinic Keratosis

PHASE3CompletedINTERVENTIONAL
Enrollment

519

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Actinic Keratosis
Interventions
DRUG

Ingenol Mebutate (Perrigo)

DRUG

Ingenol Mebutate (Reference)

DRUG

Placebo gel

Sponsors

Lead Sponsor

Padagis LLC
All Listed Sponsors
lead

Padagis LLC

INDUSTRY

NCT02385318 - To Compare Safety and Efficacy of Perrigo's Drug Product Compared to an FDA Approved Drug Product in the Treatment of Actinic Keratosis | Biotech Hunter | Biotech Hunter